SCHEMBL12017274

SCHEMBL12017274

O=C(OCC(F)(F)S(=O)(=O)O)C1CCCCC1N1CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.34
CYP3A4 P08684 2/20 0.33
TP53 P04637 2/20 0.33
TDP1 Q9NUW8 3/20 0.32
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 2/20 0.32
CYP2D6 P10635 2/20 0.32
NFKB1 P19838 1/20 0.32
OPRK1 P41145 1/20 0.32
PMP22 Q01453 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.31
CYP2C19 P33261 1/20 0.31
SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12017272 0.99 CYP3A4 (0.34) SMN1; SMN2CYP3A4TP53TDP1ALDH1A1
SCHEMBL12017273 0.89 ALDH1A1 (0.34) CYP3A4TP53TDP1ALDH1A1CYP2D6
SCHEMBL16152096 0.89 TP53 (0.31) CYP3A4TP53ALDH1A1CYP2D6GAA
SCHEMBL12015495 0.83 ALDH1A1 (0.36) CYP3A4TP53ALDH1A1KDM4ECYP2D6
SCHEMBL12015491 0.81 KDM4E (0.37) CYP3A4TP53TDP1ALDH1A1KDM4E
SCHEMBL10239118 0.79 TP53 (0.39) SMN1; SMN2CYP3A4TP53ALDH1A1CYP2D6
SCHEMBL10239120 0.79 TP53 (0.36) CYP3A4TP53ALDH1A1CYP2D6HTT
SCHEMBL10239119 0.78 TP53 (0.38) CYP3A4TP53ALDH1A1CYP2D6POLB
SCHEMBL12017240 0.77 TDP1 (0.34) SMN1; SMN2TDP1ALDH1A1OPRK1
SCHEMBL18786015 0.76 ALDH1A1 (0.42) ALDH1A1TSHRHTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9176378-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-03 US disclosed
US-8921028-B2 Salt, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-12-30 US disclosed
US-8735047-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-05-27 US disclosed
US-8574812-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-11-05 US disclosed
US-8460851-B2 Salt and photoresist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-06-11 US disclosed
US-20130022919-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-01-24 US disclosed
US-20120258404-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-11 US disclosed
US-20120231392-A1 SALT, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-09-13 US disclosed
US-20120219906-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-30 US disclosed
US-20110171576-A1 SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120231392-A1 SALT, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RER1, RCOR3, REN SMN1; SMN2 2501/4885CYP3A4 3170/4885TP53 4193/4885
US-20110171576-A1 SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME CLIC1, SLC10A6, APOL1 SMN1; SMN2 4118/4885CYP3A4 3262/4885TP53 1936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.